Ivana K. Kim, MD
, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Macular Degeneration Unit and Co-Director of the Ocular Melanoma Center, was selected to present the Paul Henkind Memorial Lecture at the Macula Society 2022 annual meeting in June. This annual award lecture recognizes a Macula Society member for their exceptional contributions to retina research.
Dr. Kim is the Evangelos S. Gragoudas Distinguished Scholar in Retina at Mass Eye and Ear. Her research focuses on the medical and surgical treatment of patients with vitreoretinal diseases and the development of new therapies for AMD and ocular melanoma. Together with colleagues Margaret DeAngelis, PhD, and Joan W. Miller, MD, she has described novel associations of genes such as RORA, ROB01, and CYP24A 1 with AMD that may highlight important pathways in AMD pathogenesis. Dr. Kim has also initiated and participates in various clinical trials involving new therapeutic approaches for uveal melanoma, and she has an ongoing collaboration with investigators at Mass General and the Broad Institute to evaluate circulating DNA as a biomarker for uveal melanoma progression.